Suppr超能文献

相似文献

1
Novel delivery approaches for cancer therapeutics.
J Control Release. 2015 Dec 10;219:248-268. doi: 10.1016/j.jconrel.2015.09.067. Epub 2015 Oct 9.
2
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16.
3
Role of integrated cancer nanomedicine in overcoming drug resistance.
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21.
4
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
5
Nanoparticles and targeted drug delivery in cancer therapy.
Immunol Lett. 2017 Oct;190:64-83. doi: 10.1016/j.imlet.2017.07.015. Epub 2017 Jul 29.
6
Advances in the Delivery of Cancer Therapeutics: A Comprehensive Review.
Curr Drug Deliv. 2018;15(1):21-36. doi: 10.2174/1567201814666170726105219.
7
Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.
Expert Opin Drug Metab Toxicol. 2016;12(3):281-9. doi: 10.1517/17425255.2016.1145655. Epub 2016 Feb 15.
8
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
10
The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Expert Opin Drug Deliv. 2017 Aug;14(8):937-957. doi: 10.1080/17425247.2017.1247804. Epub 2016 Oct 27.

引用本文的文献

1
Progress in brucellosis immune regulation inflammatory mechanisms and diagnostic advances.
Eur J Med Res. 2025 Sep 1;30(1):830. doi: 10.1186/s40001-025-03068-3.
2
Plant metabolites and functional foods in metastatic breast cancer: a supportive strategy for management.
Front Pharmacol. 2025 Jul 23;16:1631232. doi: 10.3389/fphar.2025.1631232. eCollection 2025.
4
Precision oncology: transforming cancer care through personalized medicine.
Med Oncol. 2025 Jun 9;42(7):246. doi: 10.1007/s12032-025-02817-y.
6
Innovative Approaches to Enhancing the Biomedical Properties of Liposomes.
Pharmaceutics. 2024 Nov 27;16(12):1525. doi: 10.3390/pharmaceutics16121525.
7
Cyclodextrin Drugs in Liposomes: Preparation and Application of Anticancer Drug Carriers.
AAPS PharmSciTech. 2024 Dec 5;26(1):3. doi: 10.1208/s12249-024-02999-0.
8
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
9
Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy.
Curr Pharm Des. 2024;30(37):2922-2936. doi: 10.2174/0113816128319233240725103706.

本文引用的文献

3
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases.
AAPS J. 2015 Jul;17(4):813-27. doi: 10.1208/s12248-015-9772-2. Epub 2015 Apr 29.
4
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
Mol Oncol. 2015 Aug;9(7):1421-33. doi: 10.1016/j.molonc.2015.03.013. Epub 2015 Apr 10.
5
Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer.
Curr Drug Targets. 2016;17(3):276-89. doi: 10.2174/1389450116666150420143932.
8
Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
Mol Cancer Ther. 2015 Jun;14(6):1395-403. doi: 10.1158/1535-7163.MCT-14-0915. Epub 2015 Apr 17.
9
The clinical and functional significance of c-Met in breast cancer: a review.
Breast Cancer Res. 2015 Apr 8;17(1):52. doi: 10.1186/s13058-015-0547-6.
10
Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.
J Oncol. 2015;2015:198967. doi: 10.1155/2015/198967. Epub 2015 Mar 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验